No valuation for Vedanta Biosciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($366.1M) and the funding record below are the closest available signals.
- ·The complete investor list: 38 names
- ·Watch Vedanta Biosciences: the Monday email on marks, rounds and moves
Vedanta Biosciences funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2023 | Later Stage VC | $118.5M | ▮ | ▮ |
| Jul 2021 | Later Stage VC | $68.4M | ▮ | ▮ |
| Sep 2019 | Early Stage VC | $8.0M | ▮ | ▮ |
| Dec 2018 | Early Stage VC | $45.4M | ▮ | ▮ |
Membership and data by Private Market View
How much has Vedanta Biosciences raised?
Vedanta Biosciences has raised $366 million across 4 recorded rounds since 2018. The largest was an $8 million early-stage round in Sep 2019; the most recent was an $119 million later-stage round in Mar 2023.
Vedanta Biosciences has filed 7 Form Ds with the SEC since 2019, most recently in Aug 2024 ($119 million sold to 25 investors).
How Vedanta Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Vedanta Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Vedanta Biosciences
- How much has Vedanta Biosciences raised?
- Vedanta Biosciences has raised $366.1M in total funding across 4 recorded rounds.
- When did Vedanta Biosciences last raise?
- Vedanta Biosciences last raised in Mar 2023 (Later Stage VC), raising $118.5M.